Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Tolmetin is an NSAID used to treat acute flares of various painful conditions and used for the long term management of osteoarthritis, rheumatoid arthritis, and juvenile arthritis. A non-steroidal anti-inflammatory agent (anti-inflammatory agents, NON-steroidal) similar in mode of action to indomethacin.
- Mechanism
- Curator reviewed
The mode of action of tolmetin is not known. However, studies in laboratory animals and man have demonstrated that the anti-inflammatory action of tolmetin is not due to pituitary-adrenal stimulation. Tolmetin inhibits prostaglandin synthetase in vitro and lowers the plasma level of prostaglandin E in man. This reduction in prostaglandin synthesis may be responsible for the anti-inflammatory action. Tolmetin does not appear to alter the course of the underlying disease in man.
- Primary indication
- For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, including the treatment of acute flares long-term management.Curator reviewed · 6 structured indications
- Formula / weight
- C15H15NO3 · 257.2845 g/mol (avg)
- First approval
- Canada, 1999 · United States, 1991
- Code names
- MCN-2559 · McN 2559-21-98
- Brand names
- Tolectin
Resolves to
UPSPUYADGBWSHF-UHFFFAOYSA-NSMILESCN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Tolmetin, and which of those have an active Phase 3 trial?